Loading Events

« All Events

  • This event has passed.

Exploring the implications of the delamanid phase III and STREAM trial results

December 12 @ 1:30 pm - 3:00 pm

The first ever phase III trials for multidrug-resistant TB (MDR-TB) have finally yielded results. Join Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) as we explore implications for the field, from the delamanid C213 trial and the STREAM trial to evaluate the shorter regimen for MDR-TB.

Register now!

Details

Date:
December 12
Time:
1:30 pm - 3:00 pm

Organizer

Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT)